Cost-effectiveness of asthma therapy

Show simple item record

dc.contributor.author Green, Robin J.
dc.date.accessioned 2007-07-13T07:35:33Z
dc.date.available 2007-07-13T07:35:33Z
dc.date.issued 2006-03
dc.description.abstract An important management strategy in asthma is the application of a cost-effectiveness review to the selected management principles. Efficacy, in the clinical trial setting, is the first determinant of effectiveness. However, in comparing the costeffectiveness of two or more therapeutic strategies or drugs the determinants of cost-effectiveness may require more than the simple comparison of Rand value and clinical efficacy end-points. The Rand value of a successful outcome is vital. One of the main goals of long-term asthma management is to avoid asthma-related hospital admissions. An effective asthma education programme can resolve most, if not all of the shortcomings in asthma care. In addition, adherence to guideline recommendations would result in a a decrease in unnecessary and costly (cost-ineffective) therapies. Many asthmatics in South Africa are not being treated according to local or international guideline recommendations and lastly adherence is a serious problem in asthma therapy, significantly increasing asthma management costs. en
dc.format.extent 573535 bytes
dc.format.mimetype application/pdf
dc.identifier.citation Green, RJ 2006, 'Cost-effectiveness of asthma therapy', South African Family Practice, vol. 48, no. 2, pp. 44-47. [www.safpj.co.za] en
dc.identifier.issn 1726-426x
dc.identifier.uri http://hdl.handle.net/2263/3010
dc.language.iso en en
dc.publisher Medpharm Publications en
dc.rights Medpharm Publications en
dc.subject Asthma en
dc.subject Cost-effectiveness en
dc.subject.lcsh Asthmatics
dc.subject.lcsh Therapeutics
dc.subject.lcsh Cost effectiveness
dc.title Cost-effectiveness of asthma therapy en
dc.type Article en


Files in this item

This item appears in the following Collection(s)

Show simple item record